Compared with opioids, other high impact drug classes like topicals, compound kits, combo packs, and specialty medications, represent proportionately low volume. However, they can be associated with exponentially significant costs. Recognizing the trends related to such cost drivers can help promote clinically-appropriate savings. Watch the video blog to learn more.
Welcome to the age of (humane) automation.
Each quarter, I round up and highlight some of my favorite articles written by Mitchell experts and let you know where we have been published outsi
March 2019 Kontos Kommentary The following commentary is produced monthly by Tom Kontos, Executive Vice-President, ADESA Analytical S
This is the third article in a seven-part series that highlights how technology and solution integration can result in improved claim outcomes.
The International Association of Industrial Accident Boards and Commissions (IAIABC) is an association of workers’ compensation jurisdictional regu